Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$135.97
11.228.99%
À la fermeture: -
$135.97
0.000.00%
Après les heures de négociation: 4:00 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
XPO Inc a un objectif de cours consensus de $143.06, basé sur les évaluations des 18 analystes. Le plus élevé est de $167 attribué par Goldman Sachs le décembre 12, 2024, et le plus bas est de $83 attribué par Morgan Stanley le octobre 6, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Stifel, Raymond James et Citigroup le octobre 28, 2025, octobre 14, 2025 et octobre 13, 2025. Avec un objectif de cours moyen de $148.33 entre Stifel, Raymond James et Citigroup, il y a une variation implicite de 9.09% upside pour XPO Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Stifel
Raymond James
Citigroup
JP Morgan
Morgan Stanley
1calculé à partir des notes des analystes
Notes d'analystes pour XPO
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/28/2025 | 2.96% | Stifel | $136 → $140 | Maintains | Buy | |||
10/14/2025 | 10.32% | Raymond James | $132 → $150 | Maintains | Outperform | |||
10/13/2025 | 14% | Citigroup | $152 → $155 | Maintains | Buy | |||
10/08/2025 | 5.91% | JP Morgan | $156 → $144 | Maintains | Overweight | |||
10/06/2025 | -38.96% | Morgan Stanley | $84 → $83 | Maintains | Underweight | |||
10/03/2025 | 19.14% | UBS | $150 → $162 | Maintains | Buy | |||
10/01/2025 | 2.96% | Benchmark | $140 → $140 | Reiterates | Buy → Buy | |||
09/30/2025 | 3.7% | Evercore ISI Group | $134 → $141 | Maintains | Outperform | |||
08/01/2025 | 0.02% | Stifel | $145 → $136 | Maintains | Buy | |||
08/01/2025 | 2.96% | Citigroup | $140 → $140 | Upgrade | Neutral → Buy | |||
08/01/2025 | 8.11% | Wells Fargo | $144 → $147 | Maintains | Overweight | |||
08/01/2025 | -38.22% | Morgan Stanley | $85 → $84 | Maintains | Underweight | |||
07/24/2025 | 6.64% | Stifel | $135 → $145 | Maintains | Buy | |||
07/15/2025 | 2.96% | Benchmark | $130 → $140 | Maintains | Buy | |||
07/10/2025 | 6.64% | Barclays | $135 → $145 | Maintains | Overweight | |||
07/09/2025 | 2.96% | Citigroup | $137 → $140 | Downgrade | Buy → Neutral | |||
07/08/2025 | -4.39% | JP Morgan | $121 → $130 | Maintains | Overweight | |||
07/08/2025 | 10.32% | UBS | $123 → $150 | Maintains | Buy | |||
07/07/2025 | 5.91% | Wells Fargo | $116 → $144 | Maintains | Overweight | |||
07/07/2025 | 10.32% | Oppenheimer | $126 → $150 | Maintains | Outperform | |||
07/07/2025 | 10.32% | B of A Securities | $139 → $150 | Maintains | Buy | |||
06/30/2025 | -0.71% | Truist Securities | $125 → $135 | Maintains | Buy | |||
06/18/2025 | 6.64% | Susquehanna | $138 → $145 | Maintains | Positive | |||
06/11/2025 | 2.96% | Jefferies | $135 → $140 | Maintains | Buy | |||
06/09/2025 | -0.71% | Barclays | $125 → $135 | Maintains | Overweight | |||
06/05/2025 | -3.66% | Stephens & Co. | $131 → $131 | Reiterates | Overweight → Overweight | |||
05/16/2025 | 2.23% | B of A Securities | $119 → $139 | Maintains | Buy | |||
05/01/2025 | -12.48% | B of A Securities | $131 → $119 | Maintains | Buy | |||
05/01/2025 | -3.66% | Stephens & Co. | $131 → $131 | Maintains | Overweight | |||
05/01/2025 | -11.01% | JP Morgan | $132 → $121 | Maintains | Overweight | |||
05/01/2025 | -14.69% | Wells Fargo | $130 → $116 | Maintains | Overweight | |||
05/01/2025 | -7.33% | Oppenheimer | $142 → $126 | Maintains | Outperform | |||
05/01/2025 | -9.54% | UBS | $108 → $123 | Maintains | Buy | |||
05/01/2025 | -14.69% | Evercore ISI Group | $115 → $116 | Maintains | Outperform | |||
04/30/2025 | -8.07% | Barclays | $135 → $125 | Maintains | Overweight | |||
04/24/2025 | -8.07% | Truist Securities | $130 → $125 | Maintains | Buy | |||
04/14/2025 | 4.43% | Stifel | $147 → $142 | Maintains | Buy | |||
04/09/2025 | -0.71% | Jefferies | $170 → $135 | Maintains | Buy | |||
04/08/2025 | -20.57% | UBS | $170 → $108 | Maintains | Buy | |||
04/08/2025 | -16.89% | Citigroup | $148 → $113 | Maintains | Buy | |||
04/08/2025 | -8.07% | Raymond James | $165 → $125 | Maintains | Outperform | |||
04/04/2025 | 4.43% | Oppenheimer | $176 → $142 | Maintains | Outperform | |||
04/02/2025 | -0.71% | Barclays | $150 → $135 | Maintains | Overweight | |||
03/31/2025 | 1.49% | Susquehanna | $180 → $138 | Maintains | Positive | |||
03/28/2025 | -3.66% | B of A Securities | $150 → $131 | Maintains | Buy | |||
03/27/2025 | -4.39% | Wells Fargo | $170 → $130 | Maintains | Overweight | |||
03/13/2025 | -4.39% | Truist Securities | → $130 | Initiates | → Buy | |||
03/10/2025 | 10.32% | Barclays | $165 → $150 | Maintains | Overweight | |||
03/05/2025 | 10.32% | B of A Securities | $170 → $150 | Maintains | Buy | |||
03/05/2025 | 25.76% | Stephens & Co. | $171 → $171 | Reiterates | Overweight → Overweight | |||
02/24/2025 | 8.11% | Stifel | $147 → $147 | Upgrade | Hold → Buy | |||
02/07/2025 | 17.67% | Benchmark | $155 → $160 | Maintains | Buy | |||
02/07/2025 | 21.35% | Raymond James | $170 → $165 | Maintains | Outperform | |||
02/07/2025 | 25.03% | UBS | $159 → $170 | Maintains | Buy | |||
01/23/2025 | 8.11% | Stifel | $124 → $147 | Maintains | Hold | |||
01/17/2025 | 21.35% | Barclays | $170 → $165 | Maintains | Overweight | |||
01/15/2025 | -8.8% | Stifel | $131 → $124 | Downgrade | Buy → Hold | |||
01/15/2025 | 14% | Benchmark | $150 → $155 | Maintains | Buy | |||
01/10/2025 | 21.35% | Jefferies | $150 → $165 | Maintains | Buy | |||
01/07/2025 | 25.03% | Wells Fargo | $175 → $170 | Maintains | Overweight | |||
01/07/2025 | 14% | Susquehanna | $160 → $155 | Downgrade | Positive → Neutral | |||
12/12/2024 | 22.82% | Goldman Sachs | $150 → $167 | Maintains | Buy | |||
12/12/2024 | 29.44% | Oppenheimer | $148 → $176 | Maintains | Outperform | |||
12/06/2024 | 17.67% | JP Morgan | $146 → $160 | Maintains | Overweight | |||
12/04/2024 | 21.35% | Stephens & Co. | $165 → $165 | Reiterates | Overweight → Overweight | |||
11/13/2024 | 25.03% | Barclays | $150 → $170 | Maintains | Overweight | |||
11/12/2024 | 31.65% | Citigroup | $155 → $179 | Maintains | Buy | |||
10/31/2024 | -3.66% | Stifel | $126 → $131 | Maintains | Buy | |||
10/31/2024 | 14% | Citigroup | $127 → $155 | Maintains | Buy | |||
10/31/2024 | 10.32% | Wells Fargo | $119 → $150 | Maintains | Overweight | |||
10/31/2024 | 10.32% | Barclays | $145 → $150 | Maintains | Overweight | |||
10/31/2024 | 10.32% | TD Cowen | $137 → $150 | Maintains | Buy | |||
10/21/2024 | -7.33% | Stifel | $125 → $126 | Maintains | Buy | |||
10/09/2024 | 0.02% | Goldman Sachs | $139 → $136 | Maintains | Buy | |||
10/09/2024 | -6.6% | Citigroup | → $127 | Initiates | → Buy | |||
10/04/2024 | 2.96% | Oppenheimer | $140 → $140 | Reiterates | Outperform → Outperform | |||
10/03/2024 | -8.07% | Evercore ISI Group | $129 → $125 | Maintains | Outperform | |||
09/19/2024 | 2.96% | Benchmark | $140 → $140 | Reiterates | Buy → Buy | |||
09/18/2024 | 17.67% | Susquehanna | $145 → $160 | Maintains | Positive | |||
09/06/2024 | 5.17% | JP Morgan | $147 → $143 | Maintains | Overweight | |||
09/05/2024 | 4.43% | TD Cowen | $143 → $142 | Maintains | Buy | |||
09/05/2024 | 10.32% | Stephens & Co. | $150 → $150 | Reiterates | Overweight → Overweight | |||
09/05/2024 | -12.48% | Wells Fargo | $125 → $119 | Maintains | Overweight | |||
08/05/2024 | -8.07% | Stifel | $120 → $125 | Maintains | Buy | |||
08/02/2024 | 2.96% | Benchmark | $140 → $140 | Reiterates | Buy → Buy | |||
07/22/2024 | -1.45% | B of A Securities | $135 → $134 | Maintains | Buy | |||
06/25/2024 | -8.8% | Evercore ISI Group | $144 → $124 | Maintains | Outperform | |||
06/24/2024 | -4.39% | Raymond James | $135 → $130 | Maintains | Outperform | |||
06/12/2024 | 6.64% | Susquehanna | $160 → $145 | Maintains | Positive | |||
06/07/2024 | 10.32% | Stephens & Co. | $150 → $150 | Reiterates | Overweight → Overweight | |||
06/07/2024 | -8.07% | Wells Fargo | → $125 | Initiates | → Overweight | |||
06/07/2024 | 2.96% | Benchmark | $140 → $140 | Reiterates | Buy → Buy | |||
05/24/2024 | -11.75% | Stifel | $115 → $120 | Upgrade | Hold → Buy | |||
05/06/2024 | 10.32% | Stephens & Co. | $150 → $150 | Reiterates | Overweight → Overweight | |||
05/06/2024 | 1.49% | TD Cowen | $136 → $138 | Maintains | Buy | |||
04/16/2024 | 2.96% | Benchmark | $125 → $140 | Maintains | Buy | |||
04/15/2024 | 2.23% | B of A Securities | $137 → $139 | Maintains | Buy | |||
04/15/2024 | 6.64% | Raymond James | $130 → $145 | Maintains | Outperform | |||
04/10/2024 | 2.96% | Oppenheimer | $130 → $140 | Maintains | Outperform | |||
03/11/2024 | 5.91% | JP Morgan | $122 → $144 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action XPO (XPO) ?
Le dernier objectif de prix pour XPO (NYSE:XPO) a été rapporté par Stifel le octobre 28, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $140.00 s'attendant à ce que XPO se rise dans les 12 prochains mois (un possible changement de 2.96% upside). 72 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour XPO (XPO) ?
La dernière note d'analyste pour XPO (NYSE:XPO) a été fournie par Stifel, et XPO maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour XPO (XPO) ?
La dernière amélioration pour XPO Inc a eu lieu le août 1, 2025 lorsque Citigroup a augmenté leur objectif de prix à $140. Citigroup avait précédemment a neutral pour XPO Inc.
Quand a eu lieu la dernière dégradation pour XPO (XPO) ?
La dernière réduction pour XPO Inc a eu lieu le juillet 9, 2025 lorsque Citigroup a changé leur objectif de prix de $137 à $140 pour XPO Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour XPO (XPO) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de XPO, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour XPO a été déposée le octobre 28, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 28, 2026.
La note d'analyste pour XPO (XPO) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de XPO (XPO) était un maintenu avec un objectif de prix de $136.00 à $140.00. Le prix actuel de XPO (XPO) est de $135.97, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.